Thu, May 6, 2010
Mon, January 11, 2010
Sat, January 9, 2010
Fri, January 8, 2010
Thu, January 7, 2010
Wed, January 6, 2010
Tue, January 5, 2010

Biodel Inc. to Present at 28th Annual JPMorgan Healthcare Conference on January 14th, 2010

DANBURY, Conn.--([ BUSINESS WIRE ])--Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the 28th Annual JPMorgan Healthcare Conference on Thursday, January 14, 2010 at 8:30 a.m. Pacific Time.

The JPMorgan Healthcare Conference will be held January 11-14, 2010, at the Westin St. Francis Hotel in San Francisco, California.

Interested parties may access the presentation in the investor relations section of Biodel's website at [ www.biodel.com ] which will link to a live webcast to be archived for 14 days.

About Biodel Inc.

Biodel is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes. Biodel's product candidates are developed using technology which reformulates existing FDA-approved peptide drugs. For further information regarding Biodel, please visit the company's website at [ www.biodel.com ].

BIOD-G